Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
4DMedical Ltd ( (AU:4DX) ) has provided an announcement.
4DMedical Ltd announced the issuance of 56,112 unquoted equity securities, specifically options expiring on February 29, 2028. This move is part of the company’s strategic financial maneuvers, potentially impacting its market position and offering stakeholders insights into its future growth and operational plans.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on innovative imaging solutions. The company is known for its advanced respiratory imaging technology, which aims to enhance diagnostic accuracy and patient outcomes.
Average Trading Volume: 1,654,075
Technical Sentiment Signal: Buy
Current Market Cap: A$253.7M
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.